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Context: Since the discovery of its central role in reproduction, our functional neuroanatomical
knowledge of the hypothalamic kisspeptin system is predominantly based on animal studies. Al-
though sex differences in kisspeptin expression have been shown in humans in adulthood, the
developmental origin of this sex difference is unknown.
Objectives: Our objectives were to determine 1) when during development the sex difference in
kisspeptin expression in the infundibular nucleus (INF) would emerge and 2) whether this sex
difference is related to sexual orientation or transsexuality.
Design and setting: Post-mortem hypothalamic tissues were collected by the Netherlands Brain
Bank and sections were stained for kisspeptin by immunohistochemistry.
Patients: Hypothalami of 43 control subjects were categorized into 3 periods: infant/prepubertal
(6 girls/7 boys), adult (11 women/7 men) and elderly (6 aged women/6 aged men). Eight male-to-
female (MTF) transsexuals, 3 HIV heterosexual men and 5 HIV homosexual men were also
analyzed.
Main outcome measure: We estimated the total number of kisspeptin-immunoreactive neurons
within the INF.
Results:Quantitative analysis confirmed that the human infundibular kisspeptin system exhibits a
female-dominant sex difference. The number of kisspeptin neurons is significantly greater in the
infant/prepubertal and elderly periods compared to the adult period. Finally, in MTF transsexuals
– but not homosexual men -, a female-typical kisspeptin expression was observed.
Conclusions: These findings suggest 1) that infundibular kisspeptin neurons are sensitive to cir-
culating sex steroid hormones throughout life and 2) that the sex-reversal observed in MTF trans-
sexuals might reflect, at least partially, an atypical brain sexual differentiation.
Thehumanbrain is thought to be sexually differentiatedunder the influence of testosterone acting in themale
fetus (1). A large number of morphological and neuro-
chemical sex differences induced by sex steroid hormones
during the perinatal period are found predominantly in
limbic-hypothalamic regions that participate in the neural
control of reproduction, including the secretion of gonad-
otropin-releasing hormone (GnRH) (GnRH; (2)). In the
human hypothalamus, postmortem and neuroimaging
studies have identified several structural (3–8) and func-
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tional (9–10) sex differences, some of which seemed to be
related to gender identity and sexual orientation (1,
11–13).
Human genetic studies demonstrated that kisspeptin
(14) and neurokinin B (NKB) signaling (15) are both po-
tent regulators of GnRH secretion and are therefore crit-
ically involved in theonset of puberty and themaintenance
of adult reproductive function. We recently reported that
theNKB systemexhibits a female-dominant sexdifference
in thehuman infundibular nucleus (INF) that reachedonly
significance in adulthood as well as that male-to-female
(MTF) transsexuals had a female-typical infundibular
NKB system (16). At present, only a fragmented overview
of kisspeptin expression throughout life is available in hu-
mans. Kisspeptin expression in the human brain has been
reported in fetuses (17) and adult subjects (18–20). Sex
differences were observed in adulthood with women hav-
ing a greater number of kisspeptin neurons in the INF than
men (19–20). In addition, an increase and hypertrophy of
neurons expressing kisspeptin mRNA was found after
menopause (18). However, in humans, it is unknown
when sex differences in kisspeptin expression arise during
development under the influence of sex hormones. There-
fore, in the present study, we analyzed infundibular kiss-
peptin expression from birth to old age in both sexes. By
including brain material from MTF transsexuals and ho-
mosexual men, we also investigated whether this sex dif-
ference was related to gender identity and sexual orienta-
tion or rather would reflect circulating sex steroid levels.
Materials and Methods
Human brain tissue
Hypothalami of 61 subjects (Table 1) were obtained through
autopsies by the Netherlands Brain Bank following the required
permissions for brain autopsy, use of tissue and medical infor-
mation for research purposes. The subjectswere categorized into
3 periods: infant/prepubertal, adult, and elderly periods. The
MTF transsexual group consisted of 7 sex-reassigned and estro-
gen-treated individuals and one individual who was not orchi-
dectomized but hormonally treated (see Table 2 for details). A
nontreated individual (S7)with strong cross-gender identity feel-
ings,whichwere already present since his earliest childhood, and
one female-to-male transsexualwere also analyzed. The effect of
sexual orientation on kisspeptin expression was studied in 5
homosexualmen. Since all homosexual subjects died of acquired
immunodeficiency syndrome (AIDS) or related diseases, 3 het-
erosexual men with AIDS were included in the analyses as con-
trol. Exclusion criteria for the subjects were a history of endo-
crine deregulation (ovarian, uterine or breast cancer; recent
abortion or pregnancy), use of corticosteroids or drugs affecting
the hypothalamic-pituitary-gonadal axis during the last month
before death and neurodegenerative or psychiatric diseases. For
each period of life, males and females were matched for age,
postmortem delay, and the duration of the formalin fixation
(t-tests).
Histology
Hypothalami were formalin fixed, paraffin embedded, and
cut serially in 6-m coronal sections from rostral (when the an-
terior commissure, the lamina terminalis and the optic chiasm
appeared) to caudal (until the posterior part of the mammillary
bodies). Every 100th section was collected on a SuperFrost/Plus
(Menzel, Germany) slide and stainedwith 0.5% thionin for gen-
eral orientation. To determine the border of the INF, every 50th
section of the putative INFwasmounted from the rostral start of
the median eminence until the appearance of the mammillary
bodies and stained for neuropeptide Y (NPY; 11). Once the bor-
der of the INFwas delimited byNPY staining, every 50th section
- adjacent to the NPY-stained ones - was then collected over the
whole length of the INF for kisspeptin immunohistochemistry.
Sectionswere deparaffinized and rehydrated through xylene and
decreasing grades of ethanol. Unless stated otherwise, all incu-
bations were carried out at room temperature and all washes
were performed using Tris-buffered saline (TBS; 0.05MTris and
0.9% NaCl; pH 7.6).
NPY immunohistochemistry. Sections were incubated sequen-
tially in 5% normal goat serum (NGS; 1 hour) in TBS-0.1%
Triton-X 100 (TBST), and overnight at 4°C in a rabbit poly-
clonal anti-NPY antibody (1:1000; Niepke 26/11/1988; Neth-
erlands Institute for Neuroscience, Amsterdam, The Nether-
lands). They were then incubated for 1 hour in a goat antirabbit
biotinylated antibody (Dako, Denmark; 1: 1000 in TBST) fol-
lowed by 1h in avidin–biotin complex (ABC; 1:800, Kit ABC
VectastainElitePK-6100,VectorLaboratoriesPLC,Cambridge,
UK). Finally, sections were incubated in nickel-DAB solution
(0.5 mg/ml 3,3-diaminobenzidine; Sigma Chemical, St Louis,
MO, USA; 0.01% H2O2; 2.33 mg/ml ammonium nickel sulfate
in TBS), rinsed in distilled water, dehydrated, cleared in xylene
and coverslipped with Eukitt (Sigma).
Kisspeptin immunohistochemistry.Sectionswere first processed
for antigen retrieval by placing them in citrate buffer (0.1m citric
acid, 0.1m trisodium citrate, pH 6.0) in amicrowave (5minutes,
700W). Next, sections were incubated sequentially in 5% nor-
mal donkey serum (NDS; 1 hour) in TBST, and 2x overnight at
4°C in a sheep polyclonal antikisspeptin antibody (GQ2;
1:50000; kindly provided by Dr. Stephen Bloom [Imperial Col-
legeLondon,London,UK]).Theywere then incubated for1hour
in a donkey antisheep biotinylated antibody (Dako,Denmark; 1:
1000 in TBST) followed by 1h in ABC (1:800). Finally, sections
were incubated in nickel-DAB solution, rinsed in distilled water,
dehydrated, cleared in xylene and coverslipped with Eukitt.
Antibody characterization
Kisspeptin. The GQ2 was raised in sheep against the full-length
human kisspeptin-54 peptide sequence. The specificity of the
GQ2 antibody was previously addressed by Dhillo et al (21) for
use in radioimmunoassay (RIA). The GQ2 antibody was used
successfully in previous immunohistochemical experiments on
hypothalamic sections from human (19–20) and monkey (22).
In the latter, preabsorption of the GQ2 antibody with synthetic
kisspeptin-54 peptide completely abolished kisspeptin
immunoreactivity.
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NPY. The specificity of the NPY antibody was previously dem-
onstrated by solid-phase preabsorption procedures (23–24).
Estimation of the total number of kisspeptin-ir neurons within
the INF. Estimates were made using Mercator image analysis
software (Explora Nova, La Rochelle, France), connected to a
Q-imaging Retiga EXi Fast 1294 camera mounted on a plain
objective microscope (Zeiss ImagerZ1 with Plan-NEOFLUAR
Zeiss objectives). From the section to be measured, a low mag-
nification image (2.5x objective) covering the INFwas obtained.
In this image, the INF was outlined manually (based on the ad-
jacent NPY staining) and over this outlined area a grid was su-
perimposed. From the respective grid fields, x and y coordinates
were stored and all individual imageswere retrieved using a 63
objective on the image analysis monitor. For analysis, 100% of
the rectangular fields were analyzed. To prevent double count-
ing, only kisspeptin-ir neurons containing a nucleolus (2 m
diameter) were counted. The number of neurons per section was
multiplied by the sampling frequency (the interval distances be-
tween individual sections) to obtain an estimation of the total
number of kisspeptin-ir neurons in the INF from 16.75  0.50
(mean S.E.M.) sections per subject.
Estimation of the INF volume
The INF volume was calculated with the trapezoidal compu-
tationmethod (25) that consists of two steps: 1) themeasurement








Control females (n  23)
Infant / Pubertal period (n  6) 86–027 5 m 735 10:00 40 Sudden infant death syndrome
89–027 6 m 780 17:00 28 Cardiomyopathy
97–153 7 m 760 1240 39 Sudden infant death syndrome
89–036 1 yr 820 NA 31 Hypoglycaemia
87–077 7 yr 1320 9:45 33 Astrocytoma
87–035 13 yr 1250 13:00 48 Histiocystic lymphoma, cardiac failure
Adult period (n  11) 01–009 21 yr 975 19:35 65 Myocard infarction
84–025 23 yr 1300 10:00 35 Acute myeloid leukemia
01–072 25 yr 1500 17:00 31 Found dead (epileptical seizure)
85–041 28 yr 1365 325 44 Cardiogenic shock
85–027 29 yr 1150 790 60 Corrected Fallots tetralogy; cardiac failure, hepatic coma
02–006 32 yr 1287 2460 45 Severe pulmonary hypertension
92–037 32 yr 1280 1800 45 Bronchopneumonia
99–058 34 yr 1395 72:00 132 Cardial abnormalities
91–009 36 yr 1348 71:30 61 Faecal perotonitis
84–002 36 yr 1420 5160 51 Multiple fractures; rupture of thoraci aorta
01–023 40 yr 1279 41:00 54 Pulmonary carcinoma
Elderly period (n  6) 01–004 64 yr 1159 8:35 36 Probable ileus, perforation with acute stomach
98–036 69 yr 1264 6:15 31 Cardiogenic shok
98–080 72 yr 1041 24:00 67 Respiratory failure secondary to cardiac abnormalities
98–034 72 yr NA 3930 56 Bronchopneumonia
98–104 74 yr 1207 7:25 31 Necrosis of the intestins
98–089 90 yr 1047 7:15 39 Ruptured abdominal aorta aneurism
Control males (n  20)
Infant / Pubertal period (n  7) 85–036 2,5 m 635 17:00 73 Cardiac failure, aortic stenosis,
cerebral ischemia
86–041 6 m 800 6:30 14 Sudden infant death syndrome
88–058 1 yr 1070 35:35 28 Bacterial meningitis, sepsis
88–092 1 yr 920 41:00 31 Penthotal intoxication, hypoxia
84–016 4 yr 1565 23:55 100 Sepsis
87–057 6 yr 1550 3:30 41 Peritonitis
87–036 14 yr 1640 41:00 32 Lymphadenopathy
Adult period (n  7) 97–083 22 yr 1334 16:29 26 Hypertrophic cardiomyopathy
02–076 27 yr 1520 NA NA Drowning
98–031 33 yr 1588 46:25 72 Haematothorax following car accident
99–071 39 yr 1400 16:30 130 Heart infarction
96–253 41 yr 1150 17:00 1231 Kidney failure
99–141 44 yr 1565 10:00 149 Myocard infarction
99–035 44 yr 1434 41:00 123 Multi-organ failure
Elderly period (n  6) 98–090 58 yr 1528 41:00 72 Collapsed; unsuccessful resuscitation
08–032 71 yr 1600 8:55 70 Pancreas and rectum
cacinoma with hepatic metastases
06–028 76 yr 1514 19:35 27 Cardiac arrest
97–143 79 yr 1392 6:00 31 Pulmonary embolism
97–116 80 yr 1380 6:56 33 Respiratory insufficiency, lung emphysema
09–001 88 yr 1418 4:43 51 Gastro-intestinal bleeding
Heterosexual men HIV (n  3) 89–024 21 yr 1430 2940 25 AIDS: mycobacterial infections, pneumonia, cerebrovascular accident
86–048 30 yr 1430 530 37 AIDS: pneumocystic carinii pneumonia,
lung tuberculosis, toxoplasmosis, heroin addiction
89–042 30 yr 1340 1785 25 AIDS: disseminated non-Hodkin’s lymphoma
Homosexual men HIV (n  5) 86–046 32 yr 1440 2930 11 AIDS: pneumocystic carinii pneumonia
87–080 39 yr 1320 5340 28 AIDS: progressive multifocal
leukoencephalopathy
88–087 41 yr 1240 490 34 AIDS: bronchopneumonia, cytomegalic
infections and toxoplasmosis
86–043 42 yr 1340 NA 24 AIDS: disseminated Kaposi’s sarcoma
88–121 42 yr 1340 1125 30 AIDS: cytomegalic meningoencephalitis
MTF transsexuals (n  8) 98–137 (T1) 26 yr 1500 NA NA Suicide
93–042 (T2) 36 yr 1145 21:43 31 Pneumonia
88–064 (T3) 43 yr 1540 NA NA Neurosarcoma
95–018 (T4) 48 yr 1198 40:20 36 Cardiac arrest
84–020 (T5) 50 yr 1380 NA 30 Suicide
93–070 (T6) 53 yr 1500 5760 34 Acute fatty liver
07–021 (T7) 58 yr 1358 445 37 Renal cell carcinoma
98–141 (T8) 74 yr 1118 2455 33 Multiple cerebral infarction
FTM transsexual (n  1) 98–245 51 yr 1171 4:15 32 Cachexia
Non-treated male with cross-gender identity feelings (n  1) 96–088 (S7) 84 yr 1433 41 38 Lung carcinoma
MTF: male-to-female; NA  not available; NBB: Netherlands Brain Bank.
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of the infundibular area in each section by manually tracing the
border of the INF based on NPY staining by using theMercator
image analysis software; 2) the measurement of the volume be-
tween two consecutive sections using the interpolation of the
area. The total volume of the INF is the summation of all the
interpolated volumes between sections.
kisspeptin-ir neuronal morphology in females
In order to confirm previous data showing a hypertrophy of
kisspeptin-expressing neurons after menopause (18), twenty to
thirty kisspeptin-ir neurons were randomly selected for cell area
measurement in females (n 3 for each period of life). Images of
these neurons were digitized through a video camera attached to
the microscope (100x objective) and the cell perimeters were
manually delineated for measurement of cell area with aMacin-
tosh-based image analysis system using the NIH Image program
(version 1.49; Wayne Rasband, NIH, Bethesda, MD, USA).
Statistical analysis.Data were first checked for normality using
the Shapiro-Wilk test. A Box-Cox transformation was then ap-
plied to approach (fixation time, [GRAPHIC]  –0.550) or
achieve (number of kisspeptin-ir neurons, [GRAPHIC] 0.186;
brain weight, [GRAPHIC]  2.810; postmortem delay,
[GRAPHIC]  –0.004) normality of non-normally distributed
data prior to further analyses. Statistical analyses and box and
whisker plots were generated from Box-Cox transformed data
(see original and Box-Cox transformed data in Supplemental
Table 1). Two-way ANOVAs with the stage of life (infant/pre-
pubertal vs. adult vs. elderly) and the sex (male vs. female) as
independent factors were used to analyze the overall difference
in the number of kisspeptin-ir neurons.One-wayANOVAswere
performed to assess 1) the effect of gender identity and sexual
orientation on the number of kisspeptin-ir neurons and 2) kiss-
peptin-ir neuronal morphology in females. All ANOVAs were
followed when appropriate by post hoc tests using Fisher’s pro-
tected least significant difference tests. Age effects on the number
of kisspeptin-ir neurons were addressed in a polynomial regres-
sion model for each sex separately. Analyses of covariance were
used to control for possible confounding factors such as the vol-
umeof the INF, postmortemdelay and fixation time.Differences
were considered significant for P  .05.
Results
The neuronal distribution of infundibular kisspeptin-ir
was similar to that previously reported by other groups in
humans (18–20). These neurons were almost absent from
the anterior part of the INF but were found in gradually
increasing numbers as the nucleus extends caudally, with
greatest numbers observed in themiddle to caudal parts of
the INF (Figure 1).
Overall, a greater number of kisspeptin-ir neurons was
found in females compared to males (see Figure 2 for rep-
resentative pictures).Moreover, kisspeptin expression ap-
peared to change over the lifetime, with a greater number
in the infant/prepubertal and elderly periods compared to
the adult period (Figure 3A and Supplemental Table 2 for
the original numerical values). Two-way ANOVA on the
Table 2. Hormonal profil of transsexual subjects
NBB Age
Age of
hormonal Estrogen treatment Anti-androgen treatment
number (yr) treatment / Orchidectomy
Male-to female transsexuals
(T1) 98–137 26 21 / 26 EE 50 g 2 dd. 50 mg CPA 2 dd.
(T2) 93–042 36 NA / Not orchidectomized Estradiol in combinaison with hydroxyprogesterone
in therapeutical dosages. Exact period
of treatment is not known but based on the
significant testes atrophy she was most probably
treated for a period of about 5 yr or more.
50 mg CPA 1 dd (at least the last 10 months b. d.).
(T3) 88–064 43 36 / 39 Age 39: 50 g EE 2 dd (stopped 3 months b.d.). Age 36: 50 mg CPA 2 dd (stopped 2 yr b.d.).
(T4) 95–018 48 35 / 36 Age 35–40: EE 50 g 2 dd. Age 35–40: CPA 50 mg 2dd.
Age 40: EE 50 g 1 dd (treatment lasted until death).
(T5) 84–020 50 42 / 44 Age 42: DES 5 mg 1 dd, after 2 months to 5 mg 2 dd. Age 44: CPA 50 mg 2 dd (stopped 2 yr b.d.).
Age 44: EE 50 g 2 dd (lasted until death).
(T6) 93–070 53 40 / 50 Age 40: DES treatment (stopper after 1 yr). Age 50–53: CPA 50 mg 1 dd.
Age 43–47: Premarin 0625 mg 1 dd.
Age 47–50: Premarin 3075 mg 1 dd.
Age 50–53: Premarin 2,5 mg 1 dd and topical estrogen
cream. (estrogen treatment stopped
3 months b.d.).
(T7) 07–021 58 43 / 46 Age 43: EE 50 mg 1 dd. Age 43–48: cyproteron 50 mg 1 dd.
Age 44–51: EE 50 mg 2 dd. Age 49–51: cyproteron 25 mg 1 dd.
Age 52–54: treatment has been stopped.
Age 55–57: estradiol plasters 100 mg.
(T8) 98–141 74 64 / 64 Age 64: EE 50 mg 2 dd. Age 64: 50 mg 2 dd.
Age 67: Estraderm 100 mg 1 dd.
(S7) 96–088 84 No hormonal treatment/
No orchidectomy
Female-to male transsexual
(FTM) 98–245 51 27 / 28 Age 27: Sustanon 250 mg, twice a month injections.
Age 30: TU 40 mg 3 dd.
Age 34: TU 40 mg 2 dd.
Age 36: TU 40 mg 4 dd.
Age 44: Sustanon 250 mg twice a month injections
Age 47–48: Sustanon 250 mg, every 3 weeks.
Age 48-death: no T treatment anymore
b.d., before death; DES, diethylstilbestrol; NBB, Netherlands Brain Bank; CPA, cyproterone acetate; EE, ethinyloestradiol; TU, testosterone
undecanoate.
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number of kisspeptin-ir neurons confirmed a significant
effect of sex (females  males; F1,37  6.87; P  .013), a
significant effect of the stage of life (F2,37  4.74; P 
.015), but no significant interaction effect between the two
factors (F2,37  0.096, P  .909). Post hoc test revealed
that the number of kisspeptin-ir neurons is significantly
lower in the adult period compared to the infant/prepu-
bertal (P  .032) and the elderly (P  .020) periods. No
difference was found in the number of kisspeptin-ir neu-
rons between the infant/prepubertal and the elderly period
(P  .81).
The developmental pattern of infundibular kisspeptin
expression throughout life seemed to be quite similar be-
tween men and women, ie, a moderate number of kiss-
peptin-ir neurons in the infant/prepubertal period fol-
lowed by a lower number in the adult period and an
increasing number in the elderly period (see Figure 3B and
3C). Quadratic polynomial regression analysis showed
that the number of kisspeptin-ir neurons is significantly
correlated with age in bothmales (r 0.55; P .047, n
20) and females (r  0.52; P  .042, n  23).
Furthermore, as previously described (18), most kiss-
peptin-ir neurons in the INF of postmenopausal women
showed hypertrophy (Figure 3E and F). One-way
ANOVA showed that the mean cell area of kisspeptin-ir
neuronswas significantly different among the groups (F2,6
 79.09; P .0001). Post hoc tests revealed that kisspep-
tin-ir neurons exhibited a hypertrophied morphology in
postmenopausal women (564.8  33.2, mean  SEM)
compared to premenopausal women (175.4  14.6,
mean SEM) and infant/prepubertal girls (153.5 26.7,
mean  SEM; all P  .0001). No difference was found
between infant/prepubertal girls and premenopausal
women (P  .57).
Finally, we assessed the effect of gender identity and
sexual orientation on the number of kisspeptin-ir neurons
(Figure 3D).One-wayANOVA indicated that the number
of kisspeptin-ir neurons is significantly different between
the groups (F4,29  2.975; P  .036). Post hoc tests
showed that the number of kisspeptin-ir neurons ofmen is
significantly lower compared to women (P  .044), to
MTF transsexuals (P  .005) and to HIV heterosexual
men (P  .011). No significant difference was observed
betweenHIV heterosexual men andHIV homosexual
men (P  .28). Among MTF transsexuals, linear regres-
sion analyses indicated that the number of kisspeptin-ir
Figure 1. Distribution of kisspeptin-ir neurons throughout the rostro-
caudal extent of the INF at one side of the brain in a representative 90
year-old women. The distance between 2 sections is 300 m. Note the
gradual increase of kisspeptin-ir neurons as the nucleus extends
caudally.
Figure 2. Representative photomicrographs of infundibular kisspeptin
expression in the infant/prepubertal (A, B), adult (C, D) and elderly (E,
F) periods in both sexes. The boxes in panels illustrate the area
photographed at higher magnification. Note the numerous and
intensely labeled kisspeptin neurons in the infant/prepubertal (B) and
elderly periods (F) compared to the adult period (D) in the female INF.
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neurons is neither correlatedwith age (r –0.24;P .57;
n 8) nor with the duration of hormonal treatment (r
–0.55;P .15; n 8). Finally, it is interesting to note that
the female-to-male (FTM) transsexual subject had a num-
ber of kisspeptin-ir neurons (144 neurons) in the male
range, while the untreated gender-identity disorder sub-
ject (S7) showed an intermediate number of kisspeptin-ir
neurons (1465 neurons).
Figure 3. A, Box-and-whisker plots illustrating how the number of kisspeptin-ir neurons in the INF varies and differs between males and females
during the infant/pubertal period (between 5 months and 14 years), the adult period (between 22 and 44 years) and the elderly period (between
58 and 90 years). The line represents the median and the cross represents the mean. Black dots represent individual data. Relationship between
the total number of kisspeptin-ir neurons in the INF and age in females (B) and in males (C). The lines represent the quadratic regression curve. D,
Box-and-whisker plots illustrating how the number of kisspeptin-ir neurons in the INF varies according to transsexuality and sexual orientation. E,
Box-and-whisker plots representing the neuronal hypertrophy of kisspeptin neurons after menopause. F, Representative microphotographs
illustrating the hypertrophy of neurons expressing kisspeptin in postmenopausal women (c) compared with premenopausal women (b) and infant/
prepubertal girls (a) in the INF (100x objective). * P  .05 vs. HIV- heterosexual men; # P  .05 vs. infant/prepubertal girls; P  .05 vs.
premenopausal women.
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Confounding factors
As expected, two-way ANOVA on brain weights re-
vealed a significant effect of sex (F1,36 12.19; P .001),
a significant effect of stage of life (F2,36 4.11; P .025)
but no interaction between the two factors (F2,36 1.01;
P .38). Post hoc analysis showed that the brain weights
of infant/prepubertal subjects is lower compared to both
adult (P .016) and elderly (P .041) subjects. A similar,
although not statistically significant, effect of the stage of
life (F2,37  3.15; P  .055) was observed in the volume
of the INF whereas no significant effect was observed be-
tween males and females (F1,37 0.036; P .85) and no
interaction between the two factors was found (F2,37 
0.99; P .38). To assess whether the sex and stage of life
differences observed in the number of kisspeptin-ir neu-
rons was not consecutive to a structural sex difference of
the brain area analyzed (INF) or affected by possible con-
founding factors such as postmortem delay and fixation
time, analyses of covariance were carried out. When ad-
justed for the volume of the INF or fixation time, signif-
icant effects of sex (F1,38  7.91; P  .0077 and F1,37 
6.83;P .013, respectively) and stage of life (F2,385.80;
P  .0063 and F2,37  3.61; P  .0370, respectively) on
the number of kisspeptin-ir neurons were still detected.
However, when controlled for postmortem delay, only a
significant effect of sex (F1,36  7.30; P  .0104) was
observed (stage of life effect: F2,36  2.70; P  .081).
Moreover, no difference was found in brain weights or
infundibular volume between adult men, women, MTF
transsexuals and homosexual subjects (P  .5).
Discussion
Our study provided for the first time a systematic and
quantitative analysis of kisspeptin-ir neurons along the
rostro-caudal extent of the human INF throughout life in
both sexes. We demonstrated that kisspeptin expression
shows sex differences (femalesmales) and changes over
lifetime (infant/prepubertal  adult  elderly). These
changes in kisspeptin expression in the INF likely reflect
the fluctuation in the concentration of sex steroid hor-
mones throughout life. Moreover, MTF transsexuals, but
not homosexualmen, hada female-typical numberof kiss-
peptin-ir neurons. This sex-reversal may thus reflect, at
least in part, an atypical sexual differentiation of the
hypothalamus.
Female-dominant sex difference in infundibular
kisspeptin expression
Most our knowledge about a putative sex difference in
kisspeptin expression in the human INF came from inde-
pendent studies using adult subjects. Thus, sex differences
in the number of kisspeptin neurons (femalemale) were
found in young adults (19) as well as in aged subjects (20).
In the present study, we observed an overall female-dom-
inant sex difference in the number of kisspeptin-ir neurons
in the human INF. Unfortunately, the absence of a statis-
tically significant interactionbetween the sexand the stage
of life did not allow us to unravel at which stage of life this
sex difference emerges.However, basedon themeannum-
ber of kisspeptin-ir neurons, females have quantitatively
more kisspeptin-ir neurons compared to age-matched
males at all stages of life analyzed, raising the possibility
that this sex difference is already present during childhood
andmight reflect organizational effects of sex steroidsdur-
ing early development. It is worth mentioning that the
expression of NKB in the INF – a neuropeptide involved
in the control of GnRH release (15) and which is exten-
sively coexpressed inkisspeptinneurons (19) – showed sex
differences as well (16). Moreover, by analyzing the rela-
tionshipbetweenNKB-ir andkisspeptin-ir neurons in sub-
jects that were included in both the previous (16) and the
present study, we found that the number of kisspeptin-ir
neurons was significantly and positively correlated with
the number of NKB-ir neurons (r 0.649; P 0.0001; n
37).
Development and sex steroids regulation of the
human infundibular kisspeptin system
Most of our knowledge about the developmental pat-
tern in kisspeptin expression and its regulation by sex ste-
roids is largely derived from studies in rodents. In the ro-
dent brain, kisspeptin is predominantly expressed in the
anteroventral periventricular nucleus and periventricular
nucleus (AVPV/PeN) and the arcuate nucleus (ARC, the
rodent homologue of the human INF). The AVPV/PeN
population shows sex differences (female  male), is up-
regulated by sex steroids and presumably involved in the
preovulatoryGnRH/LH surge. By contrast, theARCpop-
ulation –which shows no sex differences in adulthood – is
down-regulated by sex steroids and has been implicated in
the negative feedback action of gonadal steroids (see (26)
for a review). In humans, in situ hybridization and immu-
nohistochemical studies have failed to identify a homo-
logue of the rodent AVPV/PeN kisspeptin population. Al-
though some were found scattered within the medial
preoptic area, the vast majority of kisspeptin neurons are
located in the INF (18, 19). It is very likely that the INF
represents the hypothalamic site that mediates the nega-
tive feedback action of estradiol in primates and humans
aswell since low kisspeptinmRNAexpression is observed
in estradiol-treated ovariectomized monkeys and in pre-
menopausal women whereas kisspeptin mRNA expres-
doi: 10.1210/jc.2015-4175 press.endocrine.org/journal/jcem 7
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 26 April 2016. at 05:36 For personal use only. No other uses without permission. . All rights reserved.
sion is elevated inuntreatedovariectomizedmacaques and
postmenopausal women (18). Moreover, a similar estro-
gen regulationwasobserved forNKB(16,27).Thepresent
data corroborate these previous findings: we observed
that, in females, kisspeptin expression followed a convex
U-shaped curve throughout life, with a greater number of
kisspeptin-ir neurons in the infant/prepubertal and elderly
periods compared to the adult period. A similar, albeit not
statistically significant, effect of stage of life was observed
on kisspeptin expression in males. Our observation of a U
shaped curve in kisspeptin expression is rather unexpected
comparedwithwhat is observed in animal studies. Inmost
animal species analyzed so far, hypothalamic kisspeptin
expression increased steadily during postnatal develop-
mentwith the highest expression around puberty (see (28)
for a review). However, higher plasma levels of kisspeptin
have been reported in children compared to adults (29).
Although these concentrations were most significantly el-
evated in children at ages commonly associated with pu-
berty (9–12 years), concentrations of plasma kisspeptin in
children below 9 years of age (approx. 35 pmol/L) were
still significantly higher compared to adults (approx. 10
pmol/L). Future studies are thus needed to further dissect
kisspeptin expression during postnatal development and
puberty in human.
Female-like number of kisspeptin-ir neurons in
male-to-female transsexuals
One neurobiological theory of the origin of transsexu-
ality is based on the fact that the sexual differentiation of
the genitals (ie, in the first twomonths of pregnancy) takes
place well before the sexual differentiation of the brain
(second half of pregnancy). As the two processes are not
simultaneous, they might go into opposite directions. If
true, onemight expect to find, in transsexuals, female sex-
ual organs andmale brain structures or vice versa. Indeed,
postmortem studies investigating the brains of transsexual
individuals have observed sex-reversal in the volume and
number of neurons in the central subdivision of the sex-
ually dimorphic bed nucleus of the stria terminalis and the
third interstitial nucleus of the anterior hypothalamus
(INAH3; [5–6, 30]). Recently, we have also observed that
MTF transsexuals had a female-typicalNKBexpression in
the INF (16). In addition, structural and functional neu-
roimaging studies have observed sex-atypical neuroanat-
omical features and sex-atypical hypothalamic activation
in MTF transsexuals (13, 31–32).
In line with these previous studies, our data revealed a
female-likenumberof kisspeptin-ir neurons inMTF trans-
sexuals who had undergone estrogen treatment and sex-
reassignment in adulthood. The sex-reversal of the kiss-
peptin neuronal population in the INF of MTF
transsexuals might be explained either by the presence of
higher estrogen concentrations in the blood due to estro-
gen treatment or the lack of androgens due to orchidec-
tomy. However, based on the individual numerical data,
it appears that the number of kisspeptin-ir neurons does
not seem to be influenced by circulating hormone levels in
adulthood. Indeed, although subject T4 and T5were both
estrogen and antiandrogen-treated for approximately 8
years, subject T5 (5458 neurons) showed a much greater
number of kisspeptin-ir neurons compared to T4 (376.5
neurons). The sameobservation is true for subjects T6 and
T8. After being treated for approximately 13 and 11 years
respectively, subject T6 (5808 neurons) displayed a much
greater number of kisspeptin-ir neurons than T8 (99.5
neurons). Also, subject T2, who was never orchidecto-
mized but hormonally treated, had one of the greatest
number of kisspeptin-ir neurons (15027.5 neurons) of the
MTF transsexual group. This variability in kisspeptin ex-
pression might be explained in different but nonexclusive
ways. First, it might be attributed to different grades of
feminization over the neuronal network. Indeed, even
though MTF transsexuals might have been exposed to
atypical levels of sex hormones during development, they
were still exposed to androgens throughout life, especially
during puberty – a period that has been proposed as an
additional period during which gonadal hormones might
organize the nervous system (33). Alternatively, this vari-
ability might reflect the different mechanisms underlying
gender dysphoria, in particularly regarding the onset age
of gender dysphoric feelings (late vs early) as well as their
sexual orientation (androphilic vs gynephilic) (34). Since
the sex reversal observed in kisspeptin expression does not
seem tobe clearly influencedby circulatinghormone levels
in adulthood, our results may thus suggest a sex-atypical
development in transsexual people.
Kisspeptin expression and sexual orientation
One theory about sexual orientation suggests that it
results from low fetal exposure to testosterone, and the
absence of organizational effects of testosterone in homo-
sexualmen is responsible for feminization of certain brain
regions. Indeed, hypothalamic differences in relation to
sexual orientation have been observed. The suprachias-
matic nucleus (35) and the anterior commissure (36) are
larger in homosexual than in heterosexual men, whereas
INAH3 is smaller inhomosexual than inheterosexual sub-
jects (37). In the present study, no differencewas observed
in the number of kisspeptin-ir neurons in HIV homosex-
ual compared toHIV heterosexualmen. The statistically
significant greater number of kisspeptin-ir neurons ob-
served in HIV heterosexual men compared to HIV- het-
erosexual men is likely to be related to their AIDS status,
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as some of these patients have subnormal testosterone lev-
els and associated hypogonadism (38), and thus decreased
negative feedback as observed in the elderly period.
Concluding remarks
Our data are based on postmortem brain material de-
rived from a heterogeneous patient population. The high
variability in the number of kisspeptin-ir neurons, espe-
cially observed in females, could be partially explained by
limitations related to the use of postmortem brain tissue,
forwhich conditions at death cannot be tightly controlled.
Secondly, it should be noted that kisspeptin expression
varies across the rat estrous cycle (39). Unfortunately, the
stage of the menstrual cycle at death was not reported in
the patient’s medical folder. However, despite these lim-
itations, our data showed that females have quantitatively
more kisspeptin-ir neurons compared to age-matched
males throughout life, suggesting that this sex difference
might reflect organizational effects of sex steroids during
early development. Furthermore, the human infundibular
kisspeptin system appears to remain sensitive to gonadal
hormones throughout life since kisspeptin expression is
higher in the infant/prepubertal and elderlyperiods,which
are both characterized by low levels of circulating gonadal
hormones. Finally the sex-reversal observed inMTF trans-
sexuals might reflect, at least partially, an atypical brain
sexual differentiation.
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